EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 162 filers reported holding EAGLE PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $519,048 | -16.5% | 26,700 | +21.9% | 0.01% | -16.7% |
| Q1 2023 | $621,303 | -2.9% | 21,900 | 0.0% | 0.01% | -14.3% |
| Q4 2022 | $640,137 | +41.7% | 21,900 | +28.1% | 0.01% | +40.0% |
| Q3 2022 | $451,782 | +89.8% | 17,100 | +256.2% | 0.01% | +150.0% |
| Q1 2022 | $238,000 | -2.5% | 4,800 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $244,000 | -77.9% | 4,800 | -78.1% | 0.00% | -84.6% |
| Q1 2019 | $1,106,000 | +29.5% | 21,900 | +3.3% | 0.01% | +8.3% |
| Q4 2018 | $854,000 | +3.5% | 21,200 | +78.2% | 0.01% | +20.0% |
| Q3 2018 | $825,000 | +4.8% | 11,900 | +14.4% | 0.01% | 0.0% |
| Q2 2018 | $787,000 | +24.5% | 10,400 | -13.3% | 0.01% | +25.0% |
| Q1 2018 | $632,000 | – | 12,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JW Asset Management, LLC | 475,755 | $25,068,000 | 24.71% |
| Hudson Executive Capital LP | 971,000 | $51,162,000 | 15.09% |
| Park West Asset Management LLC | 1,051,274 | $55,392,000 | 2.47% |
| U S GLOBAL INVESTORS INC | 19,200 | $1,012,000 | 0.62% |
| Capital Impact Advisors, LLC | 26,317 | $1,387,000 | 0.57% |
| CLARK ESTATES INC/NY | 56,278 | $2,965,000 | 0.47% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 873,131 | $46,005,000 | 0.41% |
| ProQuest Associates IV LLC | 6,777 | $357,000 | 0.41% |
| Granite Investment Partners, LLC | 114,207 | $6,017,000 | 0.40% |
| GLOBEFLEX CAPITAL L P | 30,900 | $1,628,000 | 0.34% |